University Hospital of North Norway
Also known as: Eye dpt, University Hospital of North Norway | Hospital Pharmacy of North Norway Trust | Medical Clinic, University Hospital of North Norway | North Norway University Hospital, Norway | Norwegian Extra Foundation for Health and Rehabilitation | Norwegian Foundation for Health and Rehabilitation | Univeristy Hospital of North Norway | University Hospital of North Norway | University Hospital of North Norway Tromsø | University Hospital of North of Norway
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Sep 15, 2025
Timeline
2000s
- Jan 1, 2007
University Hospital of North Norway— Founded
Drugs by trial phase (88 distinct, 76 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Angina Pectoris
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Asthma
- Back Pain
- Bone Diseases, Metabolic
- Brain Diseases
- Breast Neoplasms
- Cerebral Infarction
- Cerebral Palsy
- Clostridium Infections
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Encephalitis
- Encephalomyelitis
- Endometrial Hyperplasia
- Fatigue
- Fatigue Syndrome, Chronic
- Glioblastoma
- Glucose Intolerance
- Hyperplasia
- Infarction
- Infections
- Inflammation
- Insulin Resistance
- Irritable Bowel Syndrome
- Ischemia
- Keratoconus
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Low Back Pain
- Lung Neoplasms
- Migraine Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Muscle Spasticity
- Myalgia
- Myocardial Infarction
- Myocardial Ischemia
- Osteoporosis
- Pancreatic Neoplasms
- Pneumonia
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Respiratory Sounds
- Respiratory Tract Infections
- Sclerosis
- Seminoma
- Small Cell Lung Carcinoma
- Stroke
- Syndrome
- Testicular Neoplasms
- Thrombocytopenia
- Triple Negative Breast Neoplasms
- Ulcer
Recent trials (50)
- NCT07051915CollaboratorPhase 3Sep 15, 2025
- NCT06860893Lead sponsorPhase 4Feb 23, 2025
- NCT06774261CollaboratorPhase 1Feb 1, 2025
- NCT06270407CollaboratorPhase 4Oct 31, 2024
- NCT06893250Lead sponsorPhase 2/Phase 3Sep 23, 2024
- NCT06440629CollaboratorPhase 4Aug 20, 2024
- NCT06451588Lead sponsorPhase 2Jun 1, 2024
- NCT06451588Sponsor investigatorPhase 2Jun 1, 2024
- NCT06485336CollaboratorPhase 2May 1, 2024
- NCT06248671CollaboratorPhase 2May 1, 2024
- NCT06183008CollaboratorPhase 4Feb 29, 2024
- NCT06090422Study directorPhase 1/Phase 2Jan 1, 2024
- NCT06090422Lead sponsorPhase 1/Phase 2Jan 1, 2024
- NCT06090422Overall official - principal investigatorPhase 1/Phase 2Jan 1, 2024
- NCT06090422Reponsible party - principal investigatorPhase 1/Phase 2Jan 1, 2024
Details
- Founded
- Tromsø, NO Jan 1, 2007
- Last known activity
- Sep 15, 2025